Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.040x

Based on the latest financial reports, Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a cash flow conversion efficiency ratio of 0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥227.64 Million ≈ $33.31 Million USD) by net assets (CN¥5.69 Billion ≈ $831.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review 002020 FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.

Zhejiang Jingxin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Zhejiang Jingxin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) total market value for the company's overall valuation and market capitalisation.

Zhejiang Jingxin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Jingxin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Anhui Kouzi Distillery Co Ltd
SHG:603589
-0.001x
Karooooo Ltd
NASDAQ:KARO
0.150x
Hyundai Elevator
KO:017800
0.082x
Siloam International Hospitals
JK:SILO
0.042x
Browave
TWO:3163
0.043x
OVH Groupe SAS
PA:OVH
10.219x
Australian United Investment Company Ltd
AU:AUI
0.021x
Zymeworks Inc. Common Stock
NASDAQ:ZYME
-0.098x

Annual Cash Flow Conversion Efficiency for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. View Zhejiang Jingxin Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.87 Billion
≈ $859.00 Million
CN¥781.35 Million
≈ $114.34 Million
0.133x +10.01%
2024-12-31 CN¥6.00 Billion
≈ $878.21 Million
CN¥726.16 Million
≈ $106.26 Million
0.121x -18.72%
2023-12-31 CN¥5.54 Billion
≈ $810.70 Million
CN¥824.69 Million
≈ $120.68 Million
0.149x -10.04%
2022-12-31 CN¥5.17 Billion
≈ $756.82 Million
CN¥855.78 Million
≈ $125.23 Million
0.165x +119.29%
2021-12-31 CN¥4.84 Billion
≈ $707.90 Million
CN¥365.02 Million
≈ $53.41 Million
0.075x -42.18%
2020-12-31 CN¥3.93 Billion
≈ $575.47 Million
CN¥513.21 Million
≈ $75.10 Million
0.130x -9.54%
2019-12-31 CN¥3.71 Billion
≈ $542.99 Million
CN¥535.30 Million
≈ $78.33 Million
0.144x -1.51%
2018-12-31 CN¥3.57 Billion
≈ $522.90 Million
CN¥523.40 Million
≈ $76.59 Million
0.146x +50.87%
2017-12-31 CN¥3.97 Billion
≈ $580.29 Million
CN¥385.01 Million
≈ $56.34 Million
0.097x -6.78%
2016-12-31 CN¥2.43 Billion
≈ $355.06 Million
CN¥252.69 Million
≈ $36.98 Million
0.104x +62.70%
2015-12-31 CN¥2.26 Billion
≈ $330.78 Million
CN¥144.69 Million
≈ $21.17 Million
0.064x -57.47%
2014-12-31 CN¥1.40 Billion
≈ $204.65 Million
CN¥210.49 Million
≈ $30.80 Million
0.151x +10.88%
2013-12-31 CN¥817.98 Million
≈ $119.70 Million
CN¥111.03 Million
≈ $16.25 Million
0.136x +73.98%
2012-12-31 CN¥772.58 Million
≈ $113.05 Million
CN¥60.28 Million
≈ $8.82 Million
0.078x -13.88%
2011-12-31 CN¥766.17 Million
≈ $112.11 Million
CN¥69.41 Million
≈ $10.16 Million
0.091x -51.30%
2010-12-31 CN¥320.13 Million
≈ $46.84 Million
CN¥59.55 Million
≈ $8.71 Million
0.186x -57.79%
2009-12-31 CN¥307.17 Million
≈ $44.95 Million
CN¥135.38 Million
≈ $19.81 Million
0.441x +345.67%
2008-12-31 CN¥303.19 Million
≈ $44.37 Million
CN¥29.98 Million
≈ $4.39 Million
0.099x +133.82%
2007-12-31 CN¥299.61 Million
≈ $43.84 Million
CN¥-87.60 Million
≈ $-12.82 Million
-0.292x -5856.81%
2006-12-31 CN¥294.62 Million
≈ $43.11 Million
CN¥-1.45 Million
≈ $-211.60K
-0.005x -102.30%
2005-12-31 CN¥289.64 Million
≈ $42.38 Million
CN¥61.82 Million
≈ $9.05 Million
0.213x +842.74%
2004-12-31 CN¥284.03 Million
≈ $41.56 Million
CN¥6.43 Million
≈ $940.95K
0.023x -95.66%
2003-12-31 CN¥88.44 Million
≈ $12.94 Million
CN¥46.18 Million
≈ $6.76 Million
0.522x -27.68%
2002-12-31 CN¥63.02 Million
≈ $9.22 Million
CN¥45.50 Million
≈ $6.66 Million
0.722x --

About Zhejiang Jingxin Pharmaceutical Co Ltd

SHE:002020 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.79 Billion
CN¥12.25 Billion CNY
Market Cap Rank
#6554 Global
#1343 in China
Share Price
CN¥14.23
Change (1 day)
-1.04%
52-Week Range
CN¥11.78 - CN¥21.63
All Time High
CN¥25.17
About

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemi… Read more